ALX Oncology’s (ALXO) Evorpacept Gets Orphan Drug Tag for GC Posted byZacks Equity Research January 28, 2022 Leave a comment on ALX Oncology’s (ALXO) Evorpacept Gets Orphan Drug Tag for GC The FDA bestows an Orphan Drug status to ALX Oncology’s (ALXO) lead candidate, evorpacept, for treating gastric cancer and gastroesophageal junction cancer.